Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$53.58 - $57.02 $40,452 - $43,050
755 Added 17.57%
5,053 $284,000
Q1 2024

May 08, 2024

BUY
$42.56 - $59.82 $182,922 - $257,106
4,298 New
4,298 $242,000
Q3 2023

Nov 03, 2023

BUY
$44.2 - $50.2 $85,924 - $97,588
1,944 Added 35.21%
7,465 $339,000
Q2 2023

Aug 07, 2023

SELL
$31.86 - $67.26 $472,706 - $997,936
-14,837 Reduced 72.88%
5,521 $239,000
Q1 2023

May 01, 2023

BUY
$45.44 - $74.26 $698,549 - $1.14 Million
15,373 Added 308.39%
20,358 $1.34 Million
Q4 2022

Feb 03, 2023

BUY
$41.39 - $81.0 $81,372 - $159,246
1,966 Added 65.12%
4,985 $224,000
Q3 2022

Nov 03, 2022

BUY
$72.36 - $113.1 $72,938 - $114,004
1,008 Added 50.12%
3,019 $218,000
Q2 2022

Jul 27, 2022

BUY
$87.2 - $114.05 $175,359 - $229,354
2,011 New
2,011 $216,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.